10.25384/SAGE.9089558.v1
Giuseppe Gullo
Giuseppe
Gullo
Alex J. Eustace
Alex
J. Eustace
Alexandra Canonici
Alexandra
Canonici
Denis M. Collins
Denis
M. Collins
Michael J. Kennedy
Michael J.
Kennedy
Liam Grogan
Liam
Grogan
Oscar Breathhnach
Oscar
Breathhnach
John McCaffrey
John
McCaffrey
Maccon Keane
Maccon
Keane
Michael J. Martin
Michael J.
Martin
Rajnish Gupta
Rajnish
Gupta
Gregory Leonard
Gregory
Leonard
Miriam O’Connor
Miriam
O’Connor
Paula M. Calvert
Paula M.
Calvert
Paul Donnellan
Paul
Donnellan
Janice Walshe
Janice
Walshe
Enda McDermott
Enda
McDermott
Kathleen Scott
Kathleen
Scott
Andres Hernando
Andres
Hernando
Imelda Parker
Imelda
Parker
David W. Murray
David
W. Murray
Alice C. O’Farrell
Alice C.
O’Farrell
Ashwini Maratha
Ashwini
Maratha
Patrick Dicker
Patrick
Dicker
Mairin Rafferty
Mairin
Rafferty
Verena Murphy
Verena
Murphy
Norma O’Donovan
Norma
O’Donovan
William M. Gallagher
William M.
Gallagher
Bonnie Ky
Bonnie
Ky
Dimitrios Tryfonopoulos
Dimitrios
Tryfonopoulos
Brian Moulton
Brian
Moulton
Annette T. Byrne
Annette T.
Byrne
John Crown
John
Crown
Supplementary_Methods – Supplemental material for Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial
SAGE Journals
2019
bevacizumab
breast cancer
cardiotoxicity biomarker
docetaxel/cyclophosphamide
2019-07-25 12:08:06
Journal contribution
https://sage.figshare.com/articles/journal_contribution/Supplementary_Methods_Supplemental_material_for_Pilot_study_of_bevacizumab_in_combination_with_docetaxel_and_cyclophosphamide_as_adjuvant_treatment_for_patients_with_early_stage_HER-2_negative_breast_cancer_including_analysis_of_candidate_c/9089558
<p>Supplemental material, Supplementary_Methods for Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial by Giuseppe Gullo, Alex J. Eustace, Alexandra Canonici, Denis M. Collins, Michael J. Kennedy, Liam Grogan, Oscar Breathhnach, John McCaffrey, Maccon Keane, Michael J. Martin, Rajnish Gupta, Gregory Leonard, Miriam O’Connor, Paula M. Calvert, Paul Donnellan, Janice Walshe, Enda McDermott, Kathleen Scott, Andres Hernando, Imelda Parker, David W. Murray, Alice C. O’Farrell, Ashwini Maratha, Patrick Dicker, Mairin Rafferty, Verena Murphy, Norma O’Donovan, William M. Gallagher, Bonnie Ky, Dimitrios Tryfonopoulos, Brian Moulton, Annette T. Byrne and John Crown in Therapeutic Advances in Medical Oncology</p>